Friday, March 01, 2024
Outlook.com
Outlook India
Outlook Business

Pharmaceuticals Drugs Medicines

The company witnessed 20 per cent YoY growth in 2022-23, while the quarter-on-quarter growth was 30 per cent in the second quarter of the financial year 2023-24